Sfoglia per Autore
Antitumour drugs toxicity in pituitary or adrenal ablated rats
1983-01-01 Vacca, Michele; Navarra, P.; Preziosi, P.
GABA receptor antagonists and endocrine effects of D-etomidate
1983-01-01 Preziosi, P.; Navarra, P.; Cerrito, F.; Martire, M.; Vacca, Michele
Tolerance to pituitary-adrenal axis activation by anticancer drugs in normal and tumour-bearing rats
1984-01-01 Vacca, Michele; Preziosi, P.
Anticancer drugs do not change prolactin in intact and tumour-bearing rats
1984-01-01 Vacca, Michele; Preziosi, P.; Cerrito, F.; Martire, M.; Navarra, P.
Possible neuroendocrine toxic effects of anticancer drugs in relation to the blood-brain barrier
1984-01-01 Preziosi, P.; Vacca, Michele; DEL CARMINE, R.; Cerrito, F.
GABA receptor antagonists and endocrine effects of etomidate
1984-01-01 Preziosi, P.; Cerrito, F.; Martire, M.; Vacca, Michele
Adrenocortical activation by anticancer agent hydroxyurea may be related to brain norepinephrine
1984-01-01 Preziosi, P.; Vacca, Michele; Cerrito, F.; DEL CARMINE, R.; DE GORI, N.
Unique changes of hypothalamic catecholamines during hypophyseal-adrenal stimulation by anticancer drugs
1984-01-01 Preziosi, P.; DE GORI, N.; Ragazzoni, E.; Navarra, P.; DEL CARMINE, R.; Vacca, Michele
Effects of naloxone on prolactin and corticosterone-induced release by direct and/or indirect serotonergic agents
1984-01-01 Preziosi, P.; Cerrito, F.; DE GORI, N.; Martire, M.; Vacca, Michele
Antitumour drugs toxicity in pituitary or adrenal-ablated rats
1984-01-01 Vacca, Michele; Navarra, P.; Preziosi, P.
Adrenal activation by hydroxyurea could be a protective mechanism against drug toxicity
1984-01-01 Vacca, Michele; Preziosi, P.
Possible adrenal involvement in hydroxyurea toxicity defense mechanism
1985-01-01 Preziosi, P.; Nunziata, A.; Macrae, S.; Ragazzoni, E.; Vacca, Michele
Replacement therapy against increased hydroxyurea toxicity in pituitary or adrenal ablated rats
1985-01-01 Vacca, Michele; DE GORI, N.; DEL CARMINE, R.; Navarra, P.; Preziosi, P.
Adrenal stimulation or corticosteroid replacement treatments counteract a unique hydroxyurea toxicity in pituitary-ablated rats
1985-01-01 DE GORI, N; Navarra, P; Preziosi, P; Vacca, Michele
Different effects of serotonergic antagonists on 5-HT agonist-induced changes in blood prolactin and corticosterone
1985-01-01 Preziosi, P.; Cerrito, F.; Martire, M.; Vacca, Michele
Adrenocortical activation by anticancer agents and hypothalamic epinephrine
1985-01-01 Preziosi, P.; DEL CARMINE, R.; Vacca, Michele
Specific adrenocortical activation by acceptably-tolerated long-term treatment with hydroxyurea
1985-01-01 Preziosi, P.; Vacca, Michele; Nunziata, A.; Mcsheehy, T.; Navarra, P.
Central noradenergic neurotrasmission and adrenocortical activation by hydroxyurea – a new α2-blocking agent?
1985-01-01 Carmignani, M.; Cerrito, F.; DEL CARMINE, R.; Martire, M.; Preziosi, P.; Vacca, Michele
Adrenocortical activation is independent from systemic toxicity in long-term hydroxyurea treatment.
1986-01-01 Preziosi, P.; Vacca, Michele; Nunziata, A.; Macrae, S.; Navarra, P.
Modificazioni ormonali differenziano lefetamina da oppiati
1986-01-01 Preziosi, P.; Tempesta, E.; Navarra, P.; DEL CARMINE, R.; Vacca, Michele
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile